Is Europe equipped with enough medical oncologists? Horizon still unknown

The European Society for Medical Oncology (ESMO) has welcomed a recent survey that shows the number of medical oncologists in Western Europe appears to be keeping pace with the rising toll of cancer.

But the society has also warned that a worrying lack of information about the situation in Eastern Europe must be urgently addressed.

Published in the Annals of Oncology this week, the survey provides the first detailed information on the current number of medical oncologists in 12 European Union countries, mostly in Western Europe, and their predicted availability by 2020.

Around the world countries are struggling to ensure their medical oncology systems can deal with the increase in cases, says ESMO Press Officer Solange Peters, a lung cancer expert from the university of Lausanne, Switzerland. Until now, nobody could say what the situation was in Europe.

The survey, led by Evandro de Azambuja from Jules Bordet Institute, Brussels, shows that Austria, Belgium, Bulgaria, Finland, France, Germany, Hungary, Italy, The Netherlands, Portugal, Sweden and the UK will probably have enough medical oncologists over the next 8 years since data collection to meet the needs of an increasing cancer patient population.

The study provides the current ratio of cancer cases to medical oncologists for each country, and shows the annual increase in the total number of medical oncologists.

This video is not supported by your browser at this time.
ESMO warns about the lack of information on the current and projected numbers of medical oncologists in many European countries and calls for all countries to discuss together a system allowing to obtain and continuously monitor such data.

However, despite repeated attempts, researchers were not able to gather adequate information from the 15 other EU Member States, making it impossible to paint a full picture of the situation in Europe.

"ESMO is willing to help countries work together to make this kind of data available for all of Europe," Peters says. "We need a complete picture and the current one is insufficient to draw firm conclusions."

"It is vital that we collect this data and we continuously monitor it, to optimise the system in every European country," says the ESMO spokes.

"In the long term, we hope that it might be possible to build a Europe-wide system that will ensure we have a full picture of the needs across Europe, also beyond 2020, to guarantee optimal care to cancer patients" she says.

More information: E. de Azambuja, L. Ameye, M. Paesmans, C.C. Zielinski, M. Piccart-Gebhart, M. Preusser. The landscape of medical oncology in Europe by 2020. Ann Oncol 2014; 25: 525-528 annonc.oxfordjournals.org/cont… mdt559.full.pdf+html

add to favorites email to friend print save as pdf

Related Stories

New approaches to testing cancer drugs needed

Sep 30, 2013

Research institutes, regulators and the pharmaceutical industry are urged to cooperate to develop new approaches to testing cancer drugs, in order to bring the revolution in personalised medicine to patients across Europe, ...

Community oncology: Ensuring the best standards of care

Feb 21, 2011

Receiving a cancer diagnosis is a devastating experience. Still under the shock of the bad news, patients must make many choices including who to turn to for advice and treatment, with the possibility to choose among a comprehensive ...

Recommended for you

User comments